Zantac / Ranitidine (NDMA Cancer) Lawsuit in Connecticut

Statute of Limitations

Connecticut imposes a 2-year statute of limitations for product liability and personal injury claims (C.G.S. § 52-577a, § 52-584). Connecticut courts apply a reliability-based expert admissibility standard under Conn. Code Evid. § 7-2, similar to Daubert. The discovery rule applies to latent pharmaceutical injuries. Connecticut's dense pharmaceutical corridor history creates a significant claimant population with Zantac prescription histories.

2 years from date of cancer diagnosis discovery (Daubert-like expert standard)